Want to join the conversation?
$AGN said in eye care, sales grew by 10% during 2Q16, driven by strength from RESTASIS and OZURDEX. OZURDEX delivered strong results globally with 30% growth in the US and 34% in international markets driven by its expanded diabetic macular edema label. In Aesthetics, sales grew by 14% driven by strong performance from Botox and fillers.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.